Alignment Healthcare, Inc.
$2.53B- Market cap
- $2.81B
- Debt
- +$323.18M
- Cash
- −$604.23M
Capital structure 90% equity / 10% debt · EV / Revenue 0.64x · EV / EBITDA 53.89x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 ·
Decision snapshot: ALHC stock price at discount vs QRVO $13.54 current versus $46.84 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at QRVO's multiple
Implied fair value · at ALHC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALHC FY 2025 (ended Dec 31, 2025) · QRVO FY 2026 (ended Mar 28, 2026). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 90% equity / 10% debt · EV / Revenue 0.64x · EV / EBITDA 53.89x
Capital structure 85% equity / 15% debt · EV / Revenue 2.55x · EV / EBITDA 11.63x
QRVO carries the larger enterprise value at $9.38B against $2.53B; ALHC trades on the lower EV / Revenue multiple (0.64x vs 2.55x); QRVO on the lower EV / EBITDA (11.63x vs 53.89x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ALIGNMENT HEALTHCARE, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Qorvo, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.80x
0.46x
Net debt / EBITDA
Leverage against operating earnings
-5.99x
0.41x
Cash and equivalents
Liquid reserves on the balance sheet
$604.23M
$1.22B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cigna Group
ALHC vs CI
MOLINA HEALTHCARE, INC.
ALHC vs MOH
Elevance Health, Inc.
ALHC vs ELV
CENTENE CORP
ALHC vs CNC
UNITEDHEALTH GROUP INC
ALHC vs UNH
CLOVER HEALTH INVESTMENTS, CORP. /DE
ALHC vs CLOV
SKYWORKS SOLUTIONS, INC.
ALHC vs SWKS
Broadcom Inc.
ALHC vs AVGO
Marvell Technology, Inc.
ALHC vs MRVL
ON SEMICONDUCTOR CORP
ALHC vs ON
NXP Semiconductors N.V.
ALHC vs NXPI
TEXAS INSTRUMENTS INC
ALHC vs TXN
$323.18M
$1.55B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.